Neurocrine Biosciences Shares Outstanding 2010-2024 | NBIX

Neurocrine Biosciences shares outstanding for the quarter ending September 30, 2024 were 0.104B, a 3.17% increase year-over-year.

  • Neurocrine Biosciences 2023 shares outstanding were 0.101B, a 2.12% increase from 2022.
  • Neurocrine Biosciences 2022 shares outstanding were 0.099B, a 1.02% increase from 2021.
  • Neurocrine Biosciences 2021 shares outstanding were 0.098B, a 0.1% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Neurocrine Biosciences Shares Outstanding 2010-2024 | NBIX

  • Neurocrine Biosciences 2023 shares outstanding were 0.101B, a 2.12% increase from 2022.
  • Neurocrine Biosciences 2022 shares outstanding were 0.099B, a 1.02% increase from 2021.
  • Neurocrine Biosciences 2021 shares outstanding were 0.098B, a 0.1% increase from 2020.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.